ITRM - Iterum Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue869508-
Cost of Revenue---
Gross Profit869508-
Operating Expenses
Research Development68,64725,49910,101
Selling General and Administrative8,7814,4643,258
Non Recurring---
Total Operating Expenses77,42829,96313,359
Operating Income or Loss-76,559-29,455-13,359
Income from Continuing Operations
Total Other Income/Expenses Net-254938
Earnings Before Interest and Taxes-76,559-29,455-13,359
Interest Expense-1,169-1,169-1,169
Income Before Tax-76,584-28,962-13,351
Income Tax Expense472444113
Minority Interest---
Net Income From Continuing Ops-77,056-29,406-13,464
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-77,056-29,406-13,464
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-77,056-29,406-13,464